ProCE Banner Activity

Diagnosis and Classification of Interstitial Lung Disease: Considerations for Radiologists

Clinical Thought

In this commentary, get expert insight on healthcare disparities in diagnosing interstitial lung disease, the importance of multidisciplinary discussions, and implications for timely and accurate diagnosis of fibrosing interstitial lung disease. 

Released: September 14, 2023

Share

Faculty

David Lynch

David Lynch, MB, BCh

Professor of Radiology
Medical Director
Quantitative Imaging Laboratory
National Jewish Health
Denver, Colorado

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

David Lynch, MB, BCh

Professor of Radiology
Medical Director
Quantitative Imaging Laboratory
National Jewish Health
Denver, Colorado

David A. Lynch, MB, BCh: consultant/advisor/speaker: AstraZeneca, Boehringer Ingelheim, Calyx Inc, Daiichi Sankyo.